Efficacy of L-propionyl carnitine in the treatment of chronic critical limb ischaemia

Clinical Drug Investigation

Volumn 21, Issue 8, 2001, Pages 555-561

  Santo Signorelli, Salvatore ^a   Di Pino, Luigi ^a   Costa, Maria Pia ^a   Digrandi, Daniele ^a   Pennisi, Giuseppe ^a   Marchese, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; HEPARIN CALCIUM; PENTOXIFYLLINE; PROPIONYLCARNITINE;

AGED; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN ULCER; WALKING;

EID: 0034866445     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121080-00004     Document Type: Article

References (29)

1. Prevalence of intermittent claudication and its effect on mortality
2. The prevalence of peripheral artery disease in a defined population
3. Prevalence of asymptomatic peripheral vascular disease in a group of patients older than 50
4. Peripheral artery disease-natural outcome
5. Intermittent claudication. An update on management
6. Diagnosis and treatment of chronic artery insufficiency of the lower extremities
7. Prevention of atherosclerotic complications: Controlled trial of ketanserin
8. Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive artery disease patients
9. Muscle carnitine deficiency in patients with severe peripheral vascular disease
10. Drug treatment of intermittent claudication: A critical analysis of the methods and findings of published clinical trials, 1965-1985
11. Effects of prostacyclin on fibrinolytic activity in patients with arteriosclerosis obliterans
12. Effects of iloprost on in vivo and in vitro platelet function in patients with peripheral artery disease
13. Defective fibrinolytic response in atherosclerotic patients. Effect of iloprost and its possible mechanism of action
14. The effect of iloprost on calf blood flow in patients with severe peripheral artery disease
15. 1 in chronic artery disease - A multicentre study
16. 2) for microcirculatory evaluation of peripheral artery disease
17. Microvascular and tissue oxygen distribution
18. The early effects of intravenous L-propionyl carnitine on ulcerative throphic lesions of the lower limbs in arteriopathic patients: A controlled randomized study
19. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication
20. Free radical scavenging is involved in the protective effect of L-propionyl carnitine against ischaemia-reperfusion injury of the heart
21. Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischaemia
22. Antiradical effects in L-propionylcarnitine protection of the heart against ischaemia-reperfusion injury: The possible role of iron chelation
23. Superiority of L-propionylcarnitine vs L-carnitine in improving walking capacity in patients with peripheral vascular disease: An acute intravenous, double-blind, cross-over study
24. Metabolic effects induced by L-carnitine and propionyl-L-carnitine in human hypoxic muscle tissue during exercise
25. L-propionylcarnitine effect on postexercise and postischaemic hyperemia in patients affected by peripheral vascular disease
26. Inhibitory effects of propionyl-L-carnitine on plasma extravasation induced by irritants in rodents
27. Rheological activity of propionyl-L-carnitine
28. Carnitine increases plasma level of adenosine and ATP in humans
29. Use of L-propionyl-carnitine in treatment of ischaemia of lower limbs in patients with diabetes mellitus